Atlas Trials

Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome

Clinical trial NCT02804373 · COMPLETED

Trial details

NCT number
NCT02804373
Sponsor
University Hospital, Toulouse
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Prader-Willi Syndrome
Start date
2014-06-01
Primary completion
2019-01-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.